Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $2.084B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ZYME | ZYMEWORKS INC | 22,970,388 | $392M | 18.8% | $9.83 | +45.6% | COM | 98985Y108 |
| ANAB | ANAPTYSBIO INC | 7,880,094 | $241M | 11.6% | $23.54 | -2.5% | COM | 032724106 |
| QURE | UNIQURE NV | 3,988,971 | $233M | 11.2% | $9.43 | +92.6% | SHS | N90064101 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1,706,469 | $225M | 10.8% | $120.72 | -0.6% | SHS USD | G50871105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 4,288,120 | $179M | 8.6% | $32.41 | -1.3% | COM | 22663K107 |
| CRSP | CRISPR THERAPEUTICS AG | 1,389,276 | $90.04M | 4.3% | $71.59 | -19.8% | NAMEN AKT | H17182108 |
| TNGX | TANGO THERAPEUTICS INC | 10,630,736 | $89.3M | 4.3% | $7.06 | -4.1% | COM | 87583X109 |
| ORIC | ORIC PHARMACEUTICALS INC | 6,728,116 | $80.74M | 3.9% | $15.26 | -31.1% | COM | 68622P109 |
| APLS | APELLIS PHARMACEUTICALS INC | 3,447,156 | $78.01M | 3.7% | $43.04 | -45.8% | COM | 03753U106 |
| XNCR | XENCOR INC | 6,144,767 | $72.08M | 3.5% | $32.11 | -73.0% | COM | 98401F105 |
| GLPG | GALAPAGOS NV | 1,667,119 | $57.75M | 2.8% | $32.49 | — | SPON ADR | 36315X101 |
| IMNM | IMMUNOME INC | 4,079,415 | $47.77M | 2.3% | $8.38 | +18.8% | COM | 45257U108 |
| ETON | ETON PHARMACEUTICALS INC | 2,030,544 | $44.12M | 2.1% | $9.01 | +84.1% | COM | 29772L108 |
| MBX | MBX BIOSCIENCES INC | 2,123,604 | $37.16M | 1.8% | $18.46 | -27.6% | COM | 55287L101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 75,000 | $34.4M | 1.7% | $235.62 | +58.3% | COM | 558868105 |
| RNAM | AVIDITY BIOSCIENCES INC | 765,000 | $33.33M | 1.6% | $24.25 | +66.7% | COM | 05370A108 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2,823,126 | $32.69M | 1.6% | $11.58 | — | COM NEW ADDED | 107924102 |
| NGNE | NEUROGENE INC | 1,271,342 | $22.03M | 1.1% | $14.32 | +40.2% | COM | 64135M105 |
| ALKS | ALKERMES PLC | 500,000 | $15M | 0.7% | $29.76 | -5.3% | SHS | G01767105 |
| AQST | AQUESTIVE THERAPEUTICS INC | 2,625,000 | $14.67M | 0.7% | $4.32 | 0.0% | COM | 03843E104 |
| — | METSERA INC | 271,529 | $14.21M | 0.7% | $28.22 | — | COM | 59267L107 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 550,000 | $13.34M | 0.6% | $24.25 | — | SPONSORED ADS | 152309100 |
| PRME | PRIME MEDICINE INC | 1,543,326 | $8.55M | 0.4% | $4.06 | 0.0% | COM | 74168J101 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 573,183 | $8.214M | 0.4% | $13.39 | -14.0% | COM NEW | 046513206 |
| KURA | KURA ONCOLOGY INC | 872,500 | $7.722M | 0.4% | $14.07 | -49.3% | COM | 50127T109 |
| PEPG | PEPGEN INC | 800,000 | $3.696M | 0.2% | $1.61 | 0.0% | COM | 713317105 |
| — | NUVATION BIO INC | 963,333 | $3.564M | 0.2% | $10.45 | — | *W EXP 02/10/202 | 67080N119 |
| VYGR | VOYAGER THERAPEUTICS INC | 670,303 | $3.13M | 0.2% | $3.61 | — | COM | 92915B106 |
| CMPS | COMPASS PATHWAYS PLC | 265,137 | $1.519M | 0.1% | $5.73 | — | SPONSORED ADS | 20451W101 |
| SRZNW | SURROZEN INC | 66,665 | $859K | 0.0% | $7.07 | — | *W EXP 08/01/203 | 86889P117 |